Channel Therapeutics
Why Robinhood?
You can watch CHRO and buy or sell other stocks, ETFs, and their options commission-free!About CHRO
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil.
CHRO Key Statistics
Stock Snapshot
As of today, Channel Therapeutics(CHRO) shares are valued at $13.50. The company's market cap stands at 43.66M, with a P/E ratio of -1.01.
Channel Therapeutics(CHRO) stock opened on 2026-03-31 at —. The price climbed to — and dipped to —.
The Channel Therapeutics(CHRO)'s current trading volume is 0, compared to an average daily volume of 4.4K.
In the last year, Channel Therapeutics(CHRO) shares hit a 52-week high of $54.29 and a 52-week low of $9.00.
In the last year, Channel Therapeutics(CHRO) shares hit a 52-week high of $54.29 and a 52-week low of $9.00.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.